Related Experiment Video
Updated: Mar 9, 2026
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
Luca Gallelli1, Antonio Siniscalchi2, Marco Carotenuto3
1University of Catanzaro, Clinical Pharmacology Unit, Mater Domini University Hospital - Chair of Pharmacology, Department of Health Science, School of Medicine, Catanzaro. Italy.
Abstract:
Among the clinical spectrum of neurological diseases, migraine is often associated with cerebro-vasculopathy. Impairment of neuroimmune mediators in the central nervous system has been recognized in the pathophysiology of migraine-related stroke. Although genetic correlation was found in patients with migraine-related stroke, the epidemiology of this disease indicates a need in biomarker searching discovery and validation. In this view, small molecule, called microRNAs (miRNAs), able to regulate immune and neuronal processes has been reported in patients with migraine and ischemic stroke and unambiguous miRNAs related to these diseases could be established as new molecular indicator of precocity for clinical and/or pharmacological intervention. Therefore, further exploration of this area is necessary, as greater understanding of these biomarkers could reveal the common mechanisms involved in the pathophysiology of migraine in patients with cerebral infarct.
Insights
MicroRNAs (miRNAs) show promise as biomarkers for migraine-related stroke. Identifying specific miRNAs could lead to earlier clinical and pharmacological interventions for this neurological condition.
Area of Science:
- Neurology
- Neuroscience
- Molecular Biology
Background:
- Migraine is frequently linked to cerebrovascular diseases.
- Neuroimmune pathway dysfunction is implicated in migraine-related stroke.
- Existing genetic links highlight the need for novel biomarkers.
Purpose of the Study:
- To explore microRNAs (miRNAs) as potential biomarkers for migraine-related stroke.
- To investigate the role of miRNAs in the pathophysiology of migraine and ischemic stroke.
- To identify specific miRNAs for early clinical and pharmacological interventions.
Main Methods:
- Literature review on miRNAs in migraine and stroke.
- Analysis of existing genetic and epidemiological data.
- Exploration of miRNA's regulatory roles in immune and neuronal processes.
Main Results:
- MicroRNAs (miRNAs) are small molecules regulating immune and neuronal functions.
- miRNAs have been identified in patients with both migraine and ischemic stroke.
- Specific, unambiguous miRNAs could serve as early indicators.
Conclusions:
- Further research into miRNAs is crucial for understanding migraine with cerebral infarct.
- Identifying reliable miRNA biomarkers can facilitate precocious clinical and pharmacological strategies.
- Understanding these biomarkers may reveal shared pathophysiological mechanisms.
